Increased TYRO3 and CTSH levels are associated with an increased risk of DKD in individuals with type 1 or 2 diabetes, and reduced DLK1 levels are associated with an increased risk of DKD in individuals with T2D. Here, TYRO3 is linked to diabetic kidney disease.